Hospital

The trial is the first randomized phase 3 study evaluating the efficacy and safety of ciltacabtagene autoleucel patients with relapsed and lenalidomide-refractory multiple myeloma.

The mRNA-1345 vaccine candidate was previously granted Fast Track designation by the FDA in August 2021.

Apretude is an antiretroviral drug that inhibits HIV replication by binding to the active site of integrase and blocking the strand transfer step of retroviral DNA integration.

Daprodustat (Jesduvroq, GSK) is the first oral hypoxia-inducible factor prolyl hydroxylase inhibitor to gain approval in the United States.

Kathy Pham, PharmD, BCPPS, senior director of Policy and Professional Affairs at the American College of Clinical Pharmacy (ACCP), discusses her experience at ACCP and why advocacy is important to health care and the profession of pharmacy.

Rapid antigen tests, which can identify infected individuals before they present symptoms, are considered a promising means of reducing the spread of COVID-19.

COVID-19 vaccines are known to have one of the most complex schedules that the average pharmacist has ever had to manage for a vaccine directed towards a single preventable disease.

Alcohol-related disorders were the most expensive substance type that contributed to total estimated medical cost.

The need for pharmacists to return to a more clinically-focused role became apparent as the COVID-19 pandemic revealed gaps in patient access to care across the country.

In the United States, 91% of states had lower rates of targeted therapy use than expected.

Amjevita is approved for all indications of reference Humira except for hidradenitis suppurativa.

Providers must carefully prescribe, monitor, and adjust renally relevant drug lists in patients with chronic kidney disease to prevent progression.

Patients with acute migraines should assess their condition before starting a treatment regimen.

Pharmacists play an important role in providing education and support with adherence to PrEP in populations with a high risk for HIV infection.

Intensive health behavior and lifestyle treatment is the most effective behavioral treatment for childhood obesity.

Moderator Curtis E. Haas, PharmD, FCCP; Deborah Simonson, PharmD; Andrew J. Donnelly, PharmD, MBA, FASHP; Noelle Chapman, PharmD, MBA, BCPS, FASHP; Todd Nesbit, PharmD, MBA, FASHP, discuss current challenges facing health-system pharmacies as well as potential solutions in areas such as staffing and financial stress.

Lisocabtagene maraleucel is a CD19-directed CAR T-cell therapy with a 4-1BB costimulatory domain, which enhances the expansion and persistence of the CAR T cells.

The updated label now includes patients with cold agglutinin disease with or without a history of transfusions.

A community-based multidisciplinary team can have a significant impact addressing health disparities and diabetes management.

Economic food insecurity, associated with cardiovascular mortality, disproportionately impacts Black communities.

The efficacy and adverse effects associated with COVID-19 vaccines is a leading cause of hesitancy in parents, according to a new study.

The test, called VirSNiP SARS-CoV-2 Spike F486P, is for research use only and specifically targets the unique mutation F486P found within the XBB.1.5 Omicron sub-variant.

Spinal cord stimulation has been used for 50 years to effectively manage chronic pain without opioids.

Variety of interventions improves morbidity, mortality, associated costs for patients with chronic obstructive pulmonary disorder.

Promising results for lecanemab's efficacy in patients with mild cognitive impairment or mild dementia associated with Alzheimer disease were accompanied by reports of adverse effects associated with treatment.

Mortality was highest among Asian, Black, and Hispanic populations, American Heart Association’s 2023 Statistical Update shows.

By setting a standard for prescriptions that improves member access, outcomes, and experience, we will establish a path forward for every facet of health care.

Increasing efforts have focused on treating COVID-19 among patients in rural areas, who can take advantage of traditional medicines.

Patients who received first-line ICI showed a significant improvement in progression-free survival (PFS) and overall survival (OS) compared to chemotherapy treatment.

Academic, community, first responder, government, and medical leaders call for better options to save lives.